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Sixty three percent of patients were involved in ﬂooding.
Weil Syndrome was present in six (31.8%) patients and two
of them died. The most frequent signs and symptoms were
abdominal pain 11 (50.0%), headache 15 (68.2%); vomits 14
(63.0%), and jaundice 8 (36.0%) and conjunctivitis 4 (18.2%).
There were 6 (27.3%) patients with acute renal failure (ARF),
in which 50% required hemodialysis with 2 (3.3%) deaths.
Thrombocytopenia was observed in 6 (27.3%) and albumin-
uria was present in 9 (40.9%). In 50% of patients with ARF
thrombocytopenia (<100,000mm) was present.
Conclusion: This is the ﬁrst leptospirosis outbreak that
has been reported in country. An important risk factor was
ﬂooding secondary to tropical storm. It is important to mobi-
lize health care team to surveillance directly to the areas
affected by tropical storm to detected and give prophylaxis
treatment.
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The aim of this study was to investigate the signiﬁ-
cance of multiple-mutations in the rpoB gene, predominant
nucleotide changes and its correlation with high levels
of resistance to rifampicin in Mycobacterium tuberculo-
sis isolates that were randomly collected from sputa of
44 patients with primary and secondary active pulmonary
tuberculosis from different region of Belarus. Drug sus-
ceptibility testing was determined using the CDC standard
conventional proportional method. DNA extraction, rpoB
gene ampliﬁcation, and DNA sequencing analysis were per-
formed. Thirt- three (75%) isolates were found to have
multiple-mutations (composed of 2—5 mutations) in the
rpoB (-subunit) gene. Increased number of predominant
mutations and nucleotide changes were demonstrated in
codons 523 (GGG→GCG), 531 (TCG→TTG), 510 (CAG→TAG,
GAG, AAG) and 526 (CAC→CTC, GAC) with a higher fre-
quency of mutations found among patients presenting with
secondary tuberculosis infection with elevated levels of
resistance to rifampicin (MIC g/ml≥ 100). Furthermore it
was demonstrated that the combination of mutations with
their predominant nucleotide changes were also observed
in codons 510, 523, 526, and 531 indicating higher frequen-
cies of mutations among patients with secondary infection
respectively. In this study, 76% (n = 38) of multiple-mutated
isolates were found to have mutation combinations involv-
ing nucleotide changes in codons 523 (GGG→GCG), 531
(TCG→TTG), 526 (CAC→CTC, GAC), and demonstrating pre-
dominant mutations in the last nine codons of -subunit
(523—531) are associated with higher levels of resistance
to rifampicin (≥100g/ml).
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We investigated the clinical outcome of MDR versus
non-MDR tuberculosis and the cause of recurrences in Rwan-
dese patients by DNA ﬁngerprinting. From January 2002 to
September 2005, 710 patients in 4 provinces were studied.
Initial drug susceptibility results available for 638 patients,
classiﬁed 68 (10.8%) patients as habouring Mycobacterium
tuberculosis isolates resistant to at least isoniazid and
rifampin (multidrug resistance, MDR), and 570 patients as
non-MDRTB patients. Among the 68 MDRTB patients, 21 who
failed treatment had follow-up isolates. Among the 570
patients, 558 were cured and 12 were lost to follow-up.
Recurrent disease was recorded in 2 of 558 non-MDRTB and
11 MDRTB patients with follow-up isolates. DNA patterns of
sequential isolates from 5 patients (3 MDR and 2 non-MDR)
TB patients were different, indicating reinfection caused
the recurrence. Mixed infection was detected in one non-
MDRTB case. Indistinguishable DNA patterns were obtained
from isolates of the other 8 MDRTB patients suggesting reac-
tivation or treatment failure as the cause of the recurrence.
Follow-up isolates from all the 10 chronic MDRTB patients
had identical DNA patterns, indicating treatment failure.
These results document a high treatment failure rate for
MDRTB and show that reinfection is an infrequent cause of
recurrent TB in this setting.
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